https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / Prostate 2009 May;69(6):571-84
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / Prostate 2009 May;69(6):571-842009-05-01 00:00:002019-02-15 08:53:02Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / J. Immunother. 2009 May;32(4):333-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / J. Immunother. 2009 May;32(4):333-402009-05-01 00:00:002019-02-15 08:48:40Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-05-01 / Int J Hyperthermia 2009 May;25(3):210-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-05-01 / Int J Hyperthermia 2009 May;25(3):210-92009-05-01 00:00:002009-05-01 00:00:00Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-15 / J. Cell. Biochem. 2009 Apr;106(6):999-1009
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-15 / J. Cell. Biochem. 2009 Apr;106(6):999-10092009-04-15 00:00:002019-02-15 09:17:34Nitric oxide-mediated inhibition of NFkappaB regulates hyperthermia-induced apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-11 / Urol. Oncol. 2010 May-Jun;28(3):290-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-11 / Urol. Oncol. 2010 May-Jun;28(3):290-52009-04-11 00:00:002019-02-15 08:53:01Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-10 / Cancer Immunol. Immunother. 2009 Jul;58(7):1169-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-10 / Cancer Immunol. Immunother. 2009 Jul;58(7):1169-742009-04-10 00:00:002019-02-15 08:48:09Vaccination strategies in patients with renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-08 / Eur. J. Cancer 2009 Jul;45(11):1969-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-08 / Eur. J. Cancer 2009 Jul;45(11):1969-782009-04-08 00:00:002019-02-15 08:35:44Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-01 / Expert Opin Investig Drugs 2009 Apr;18(4):509-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-01 / Expert Opin Investig Drugs 2009 Apr;18(4):509-192009-04-01 00:00:002019-02-15 08:46:47DCVax-Brain and DC vaccines in the treatment of GBM
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-01 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Apr;73(5):1538-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-01 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Apr;73(5):1538-442009-04-01 00:00:002019-02-15 09:17:35Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-04-01 / J. Immunol. 2009 Apr;182(7):3960-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-04-01 / J. Immunol. 2009 Apr;182(7):3960-42009-04-01 00:00:002019-02-15 09:21:54Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells
